Pzena Investment Management Reduces $29M in Universal Health Services, Inc. ($UHS)
Key Points
- Pzena Investment Management changed its Universal Health Services, Inc. ($UHS) stake by 9.5% last quarter, cutting to 1,912,235 shares worth $279.99 million.
- Wall Street's consensus rating on $UHS is Buy and an average price target of $215.76.
- $UHS last traded around $146.42.
Pzena Investment Management trimmed its position in Universal Health Services, Inc. ($UHS) by 9.5% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,912,235 shares of Universal Health Services, Inc. after selling 200,369 shares during the quarter. Pzena Investment Management's holdings in Universal Health Services, Inc. were worth $279.99 million as of its most recent filing.
Universal Health Services, Inc. ($UHS) Stock
Universal Health Services, Inc. Earnings
Universal Health Services, Inc. Dividend
Analysts Set New Price Targets
About Universal Health Services, Inc.
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.